OOIR: Observatory of International Research

Papers

(The H4-Index of Inflammopharmacology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients	219
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease	150
Role of vitamins and minerals as immunity boosters in COVID-19	106
COVID-19 vaccines and decreased transmission of SARS-CoV-2	103
Exosome engineering in cell therapy and drug delivery	93
COVID-19 and the role of cytokines in this disease	64
The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies	61
Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs	57
Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies	57
Health benefits of cyanidin-3-glucoside as a potent modulator of Nrf2-mediated oxidative stress	51
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons	49
Brief review of the mRNA vaccines COVID-19	46
Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2	43
A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease	43
COVID-19 and corticosteroids: a narrative review	43
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close	42
Natural compounds as safe therapeutic options for ulcerative colitis	40
The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases	38
Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action	38
Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome	37
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals	36
Microglia polarization in nociplastic pain: mechanisms and perspectives	35
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, place	34
Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis	34
Standardised pomegranate peel extract lavage prevents postoperative peritoneal adhesion by regulating TGF-β and VEGF levels	34

Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases	32
Therapeutic benefits of flavonoids against neuroinflammation: a systematic review	31
Nerolidol: a potential approach in rheumatoid arthritis through reduction of TNF-α, IL-1β, IL-6, NF-kB, COX-2 and antioxidant effect in CFA-induced arthritic model	30
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19	30